In vitro activities of daptomycin, ciprofloxacin, and other antimicrobial agents against the cells and spores of clinical isolates of Bacillus species

Journal of Clinical Microbiology

Volumn 44, Issue 10, 2006, Pages 3814-3818

  Citron, Diane M ^a   Appleman, Maria D ^b  

^a LAC USC MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS; BACILLUS CEREUS; BACTEREMIA; BACTERIAL CELL; BACTERIAL SPORE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG ACTIVITY; ENDOPHTHALMITIS; GENE SEQUENCE; HUMAN; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIODONTITIS; PNEUMONIA; PRIORITY JOURNAL; DOSE RESPONSE; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; BACILLUS; CIPROFLOXACIN; DAPTOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; MICROBIAL SENSITIVITY TESTS; SPORES, BACTERIAL;

EID: 34248683228     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00881-06     Document Type: Article

References (25)

1. Andrews, J. M., and R. Wise. 2002. Susceptibility testing of Bacillus species. J. Antimicrob. Chemother. 49:1040-1042.
2. Blue, S. R., V. R. Singh, and M. K. Saboulle. 1995. Bacillus licheniformis bacteremia: five cases associated with indwelling central venous catheters. Clin. Infect. Dis. 20:629-633.
3. Braga, P. C., D. Ricci, and M. Del Sasso. 2002. Daptomycin morphostructural damage in Bacillus cereus visualized by atomic force microscopy. J. Chemother. 14:336-341.
4. Castagnola, E., F. Fioredda, M. A. Barretta, L. Pescetto, A. Garaventa, E. Lanino, C. Micalizzi, R. Giacchino, and G. Dini. 2001. Bacillus sphaericus bacteremia in children with cancer: case reports and literature review. J. Hosp. Infect. 48:142-145.
5. Chu, W. P., T. L. Que, W. K. Lee, and S. N. Wong. 2001. Meningoencephalitis caused by Bacillus cereus in a neonate. Hong Kong Med. J. 7:89-92.
6. Clinical and Laboratory Standards Institute. 2003. M7-A6. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard - 6th ed. Clinical and Laboratory Standards Institute, Wayne, Pa.
7. Clinical and Laboratory Standards Institute. 2005. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Proposed guideline. CLSI document M-45P. Clinical and Laboratory Standards Institute, Wayne, Pa.
8. Coker, P. R., K. L. Smith, and M. E. Hugh-Jones. 2002. Antimicrobial susceptibilities of diverse Bacillus anthracis isolates. Antimicrob. Agents Chemother. 46:3843-3845.
9. Damgaard, P. H., P. E. Granum, J. Bresciani, M. V. Torregrossa, J. Eilenberg, and L. Valentino. 1997. Characterization of Bacillus thuringiensis isolated from infections in burn wounds. FEMS Immunol. Med. Microbiol. 18:47-53.
10. Dubouix, A., E. Bonnet, M. Alvarez, H. Bensafi, M. Archambaud, B. Chaminade, G. Chabanon, and N. Marty. 2005. Bacillus cereus infections in traumatology-orthopaedics department: retrospective investigation and improvement of healthcare practices. J. Infect. 50:22-30.
11. Essex, R. W., P. G. Charles, and P. J. Allen. 2004. Three cases of post-traumatic endophthalmitis caused by unusual bacteria. Clin. Exp. Ophthalmol. 32:445-447.
12. Frankard, J., R. Li, F. Taccone, M. J. Struelens, F. Jacobs, and A. Kentos. 2004. Bacillus cereus pneumonia in a patient with acute lymphoblastic leukemia. Eur. J. Clin. Microbiol. Infect. Dis. 23:725-728.
13. Gaur, A. H., C. C. Patrick, J. A. McCullers, P. M. Flynn, T. A. Pearson, B. I. Razzouk, S. J. Thompson, and J. L. Shenep. 2000. Bacillus cereus bacteremia and meningitis in immunocompromised children. Clin. Infect. Dis. 32:1456-1462.
14. Hannah, W. N., and P. T. Ender. 1999. Persistent Bacillus licheniformis bacteremia associated with an intentional injection of organic drain cleaner. Clin. Infect. Dis. 29:659-661.
15. Helgason, E., D. A. Caugant, I. Olsen, and A. Kolsto. 2000. Genetic structure of population of Bacillus cereus and B. thuringiensis isolates associated with periodontitis and other human infections. J. Clin. Microbiol. 38:1615-1622.
16. Hilliard, N. J., R. L. Shelonka, and K. B. Waites. 2003. Bacillus cereus bacteremia in a preterm neonate. J. Clin. Microbiol. 41:3441-3444.
17. Jones, B. L., M. F. Hanson, and N. A. Logan. 1992. Isolation of Bacillus licheniformis from brain abscess following a penetrating orbital injury. J. Infect. 24:103-104.
18. Kotiranta, A., K. Lounatmaa, and M. Haapasalo. 2000. Epidemiology and pathogenesis of Bacillus cereus infections. Microbes Infect. 2:189-198.
19. Logan, N. A., and P. C. Turnbull. 2003. Bacillus and other aerobic endospore-forming bacteria, p. 445-460. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
20. Maucour, M. F., C. Brugniart, A. Ducasse, L. Brasme, and O. Bajolet. 1999. Bacillary endophthalmitis: four case reports. J. Fr. Ophthalmol. 22:371-376.
21. Mohammed, M. J., C. K. Marston, T. Popovic, R. S. Weyant, and F. C. Tenover. 2002. Antimicrobial testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J. Clin. Microbiol. 40:1902-1907.
22. Steenbergen, J. N., J. Adler, G. M. Thorne, and F. P. Tally. 2005. Daptomycin: a lipopeptide antibiotic for the treatment of serious gram-positive infections. J. Antimicrob. Chemother. 55:283-288.
23. Tedesco, K. L., and M. J. Rybak. 2004. Daptomycin. Pharmacotherapy 24:41-57.
24. Turnbull, P. C., N. M. Sirianni, C. L. LeBron, M. N. Samaan, F. N. Sutton, A. E. Reyes, and L. F. Peruski. 2004. MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest. J. Clin. Microbiol. 42:3626-3634.
25. Weber, D. J., S. M. Saviteer, W. A Rutula, and C. A. Thomann. 1988. In vitro susceptibility of Bacillus spp. to selected antimicrobial agents. Antimicrob. Agents Chemother. 32:642-645.